Preferred Ipa of California, a Professional Medical Corporation

Preferred Ipa of California, a Professional Medical Corporation was paid $5.14M by Medicaid between Jan 2018 and Aug 2021, across 454 billing codes. Its largest line is 99285, emergency room visit (most serious) — 6.6% of everything it billed.

33Billing provider infoPREFERRED IPA OF CALIFORNIA, A PROFESSIONAL MEDICAL CORPORATION
GLENDALE, CA 91202

33aNPI1295992725assigned 05/21/2008

33bProvider typeGeneral Practice Physician

28Total paid$5.14M

24GClaims497,993

24DCodes billed454

24AFirst – last monthJan 2018 – Aug 2021

Compared with peers

Next to other General Practice Physician providers in California

Rank by total paid#11 of 474

Median peer was paid$10K

This provider vs. median496×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	250,152	$2.16M
2019	13,308	$165K
2020	109,110	$1.42M
2021	125,423	$1.40M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.6%	4,923	4,469	$340K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.5%	5,572	5,301	$334K
J3490	Unclassified drugs	6.2%	2,525	1,985	$321K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	6.2%	5,457	1,152	$321K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.5%	5,557	5,309	$284K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.0%	45,602	41,152	$256K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.6%	5,598	1,811	$184K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.2%	7,354	6,782	$164K
77067	Screening mammography, bilateral, including computer-aided detection	2.5%	1,319	1,319	$128K
99281	Emergency department visit for the evaluation and management, self-limited or minor	2.4%	3,946	2,575	$124K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.4%	1,790	1,780	$123K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	2.1%	4,861	1,564	$106K

442 more codes

99203	Doctor's office visit, new patient (routine)	2.1%	2,027	$106K
99199	Unlisted special service, procedure or report	1.9%	2,428	$99K
99223	Prolong inpt eval add15 m	1.7%	362	$87K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.7%	8,919	$86K
A0427	Emergency ambulance ride, advanced life support	1.2%	569	$64K
A0429	Emergency ambulance ride, basic life support	1.1%	507	$59K
76700	Ultrasound, abdominal, real time with image documentation; complete	1.1%	821	$58K
99215	Doctor's office visit, returning patient (complex)	1.1%	586	$55K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,425	$51K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	1,046	$50K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	497	$47K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	994	$44K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	411	$42K
T4541	Incontinence product, disposable underpad, large, each	<1%	1,035	$42K
97164		<1%	594	$41K
76830	Ultrasound, transvaginal	<1%	756	$41K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,859	$40K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	13,047	$40K
A0425	Ground mileage, per statute mile	<1%	1,611	$38K
70450	Computed tomography, head or brain; without contrast material	<1%	613	$38K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	129	$35K
80053	Comprehensive metabolic panel	<1%	24,892	$35K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,253	$34K
97162		<1%	459	$33K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	432	$31K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	807	$31K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	113	$30K
71046	Radiologic examination, chest; 2 views	<1%	1,420	$29K
T4535	Disposable liner/shield/guard/pad/undergarment, for incontinence, each	<1%	613	$28K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	29,599	$27K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	121	$25K
99232	Hospital visit by a doctor, follow-up day	<1%	1,019	$25K
H1001	Prenatal care, at-risk enhanced service; antepartum management	<1%	603	$24K
76641		<1%	286	$23K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	392	$22K
71045	Radiologic examination, chest; single view	<1%	3,823	$22K
T4523	Adult sized disposable incontinence product, brief/diaper, large, each	<1%	261	$21K
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	<1%	180	$20K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	825	$20K
V2020	Frames, purchases	<1%	929	$19K
S9083	Global fee urgent care centers	<1%	314	$18K
86003		<1%	663	$18K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,008	$18K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	145	$17K
59425		<1%	1,009	$17K
92340	Fitting of spectacles, except for aphakia; monofocal	<1%	787	$16K
A4267	Contraceptive supply, condom, male, each	<1%	804	$16K
97001		<1%	30	$15K
80048	Basic metabolic panel (calcium, ionized)	<1%	5,227	$14K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	563	$14K
76770		<1%	237	$13K
77065	Tomosynthesis, mammo	<1%	91	$13K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	75	$13K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	2,113	$12K
77066	Tomosynthesis, mammo	<1%	79	$11K
92015	Determination of refractive state	<1%	1,485	$11K
76536		<1%	218	$11K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	735	$11K
97803		<1%	686	$11K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	221	$10K
81025		<1%	2,806	$10K
72100		<1%	408	$10K
76642		<1%	176	$10K
99205	Prolong outpt/office vis	<1%	75	$10K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	41	$10K
96375	Therapeutic injection; each additional sequential IV push	<1%	273	$9K
90686		<1%	1,205	$9K
K0001	Standard wheelchair	<1%	242	$9K
94760		<1%	1,013	$9K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	527	$9K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	217	$9K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	388	$9K
99201		<1%	162	$9K
80061	Lipid panel	<1%	18,391	$9K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	398	$9K
90651		<1%	283	$9K
87806		<1%	566	$9K
83036	Hemoglobin; glycosylated (A1C)	<1%	14,621	$8K
73030		<1%	398	$8K
73630		<1%	516	$8K
97161		<1%	84	$7K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	14	$7K
73221		<1%	26	$7K
97802		<1%	1,184	$7K
84443	Thyroid stimulating hormone (TSH)	<1%	15,687	$7K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	295	$7K
73562		<1%	396	$7K
E0601	Continuous positive airway pressure (cpap) device	<1%	120	$6K
S4993	Contraceptive pills for birth control	<1%	218	$6K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	137	$6K
90715		<1%	332	$6K
87799		<1%	94	$6K
95117		<1%	733	$6K
81001		<1%	9,947	$6K
95115		<1%	297	$5K
73610		<1%	350	$5K
73130		<1%	305	$5K
S9999	Sales tax	<1%	871	$5K
E0443	Portable oxygen contents, gaseous, 1 month's supply = 1 unit	<1%	94	$5K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	702	$5K
72141		<1%	16	$4K
0450	Emergency room services	<1%	101	$4K
80076		<1%	1,695	$4K
84484		<1%	1,185	$4K
90670		<1%	368	$4K
70486		<1%	29	$4K
84403		<1%	388	$4K
83690		<1%	1,954	$4K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	16	$4K
93000		<1%	351	$4K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	7,403	$4K
E0562	Humidifier, heated, used with positive airway pressure device	<1%	207	$3K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	218	$3K
72040		<1%	133	$3K
87086	Culture, bacterial; quantitative colony count, urine	<1%	5,023	$3K
96361	Intravenous infusion, hydration; each additional hour	<1%	133	$3K
77080		<1%	62	$3K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	1,100	$3K
88304		<1%	133	$3K
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	<1%	159	$3K
90734		<1%	307	$3K
T4536	Incontinence product, protective underwear/pull-on, reusable, any size, each	<1%	155	$3K
97014		<1%	386	$3K
T4522	Adult sized disposable incontinence product, brief/diaper, medium, each	<1%	37	$3K
87522	Neg quan hep c or qual rna	<1%	56	$3K
71250		<1%	26	$3K
85610		<1%	2,747	$3K
74178		<1%	13	$3K
82962		<1%	1,251	$2K
86580		<1%	520	$2K
92134		<1%	89	$2K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	29	$2K
92557		<1%	26	$2K
83735		<1%	2,153	$2K
J7030	Infusion, normal saline solution , 1000 cc	<1%	324	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	370	$2K
90633		<1%	232	$2K
86592		<1%	5,488	$2K
83880		<1%	293	$2K
90700		<1%	229	$2K
84703		<1%	657	$2K
84702		<1%	1,056	$2K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	54	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	204	$2K
85027		<1%	4,549	$2K
81003		<1%	6,431	$2K
76801		<1%	37	$2K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	12	$2K
85018		<1%	3,523	$2K
90716		<1%	203	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	298	$2K
99239	Hospital discharge day management, more than 30 minutes	<1%	235	$2K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	278	$2K
36415	Collection of venous blood by venipuncture	<1%	9,279	$2K
74018		<1%	188	$2K
73502		<1%	73	$2K
84479		<1%	1,435	$2K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	39	$2K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	246	$2K
84439		<1%	5,125	$2K
73110		<1%	114	$2K
73560		<1%	102	$1K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	2,473	$1K
90707		<1%	152	$1K
90658		<1%	165	$1K
A0424	Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)	<1%	90	$1K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	1,407	$1K
90649		<1%	134	$1K
83605		<1%	282	$1K
90648		<1%	141	$1K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	363	$1K
85730		<1%	2,035	$1K
82947		<1%	1,239	$1K
73620		<1%	77	$1K
90688		<1%	251	$1K
93970		<1%	14	$1K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,236	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,691	$1K
T4526	Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each	<1%	26	$1K
87210		<1%	281	$1K
87040		<1%	301	$989.74
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	1,013	$955.86
93325		<1%	12	$934.56
86850		<1%	449	$929.37
90620		<1%	116	$926.10
93320		<1%	12	$918.84
97163		<1%	12	$900.78
90680		<1%	116	$900.00
J2270	Injection, morphine sulfate, up to 10 mg	<1%	122	$891.05
86480		<1%	312	$870.49
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	56	$870.32
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	267	$849.40
G8419	Bmi documented outside normal parameters, no follow-up plan documented, no reason given	<1%	25	$833.69
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	30	$831.35
97535	Self-care/home management training, each 15 minutes	<1%	148	$830.00
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	429	$791.78
83655		<1%	2,070	$788.19
87631		<1%	64	$749.58
84550		<1%	2,406	$748.29
82274		<1%	1,578	$737.76
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	14	$732.06
88142		<1%	291	$711.33
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	381	$646.33
87186		<1%	1,143	$628.01
93042		<1%	195	$610.02
76870		<1%	12	$606.38
84402		<1%	61	$573.27
84100		<1%	1,144	$559.29
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	80	$558.68
90713		<1%	64	$558.00
88307		<1%	15	$555.28
G8418	Bmi is documented below normal parameters and a follow-up plan is documented	<1%	29	$550.17
86901		<1%	802	$539.67
87340		<1%	1,119	$534.27
84153		<1%	1,512	$534.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,341	$468.43
86900		<1%	737	$421.90
83540		<1%	1,423	$420.91
92133		<1%	15	$419.25
82977		<1%	450	$411.00
84480		<1%	1,384	$402.15
Q3014	Telehealth originating site facility fee	<1%	12	$396.41
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	89	$390.06
87070		<1%	1,674	$389.83
82607		<1%	1,816	$373.16
86803		<1%	1,093	$361.78
82570		<1%	2,767	$360.40
82728		<1%	1,166	$355.94
81002		<1%	1,282	$354.29
80074		<1%	1,100	$334.21
86140		<1%	1,746	$333.28
87077		<1%	809	$333.12
90656		<1%	48	$315.00
87081		<1%	745	$309.98
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	151	$307.86
85652		<1%	2,175	$278.09
85049		<1%	245	$277.51
86038		<1%	1,098	$262.69
99173		<1%	3,947	$256.00
97010		<1%	1,004	$249.00
86704		<1%	45	$245.90
81000		<1%	1,340	$229.59
73140		<1%	30	$221.57
84436		<1%	2,510	$219.99
92083		<1%	12	$218.79
82746		<1%	1,118	$213.54
87088		<1%	2,200	$209.77
85007		<1%	267	$205.47
99244	Office or other outpatient consultation, moderate to high complexity	<1%	13	$204.25
36416		<1%	54	$201.93
83721		<1%	469	$200.98
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	45	$198.22
99401		<1%	1,110	$190.22
73590		<1%	14	$187.47
S9088	Services provided in an urgent care center (list in addition to code for service)	<1%	589	$179.52
83002		<1%	399	$177.94
82043		<1%	2,855	$163.03
84481		<1%	1,560	$161.68
96156		<1%	630	$160.64
83550		<1%	1,141	$148.28
86706		<1%	421	$146.40
86703		<1%	12	$143.52
82550		<1%	358	$134.90
99000		<1%	4,004	$131.12
88141		<1%	257	$126.36
90660		<1%	14	$126.00
82785		<1%	496	$124.79
83001		<1%	493	$124.28
83615		<1%	291	$124.15
99383		<1%	28	$119.70
86225		<1%	142	$117.59
90723		<1%	12	$108.00
3008F		<1%	7,078	$106.61
88312		<1%	68	$103.99
82248		<1%	853	$98.88
83970		<1%	123	$95.89
83986		<1%	188	$93.99
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	12	$91.96
80081		<1%	287	$90.69
90696		<1%	13	$90.00
84146		<1%	300	$85.41
86769		<1%	29	$84.26
80069		<1%	58	$79.41
86696		<1%	207	$77.09
92551		<1%	3,552	$76.22
84460		<1%	597	$71.52
84155		<1%	80	$70.34
83013		<1%	244	$69.20
87338		<1%	201	$63.69
82652		<1%	682	$63.67
86376		<1%	366	$61.88
87177		<1%	161	$61.27
85379		<1%	13	$60.55
84144		<1%	13	$57.03
86735		<1%	20	$53.31
84450		<1%	494	$52.65
86695		<1%	190	$52.54
92552		<1%	1,844	$51.09
83021		<1%	50	$46.20
73090		<1%	13	$45.66
82565		<1%	185	$38.71
86762		<1%	145	$35.58
85651		<1%	48	$35.33
87147		<1%	361	$33.63
84075		<1%	50	$30.09
0270		<1%	18	$28.44
82150		<1%	128	$28.12
85014		<1%	162	$24.31
86709		<1%	13	$23.31
82950		<1%	336	$20.33
86431		<1%	877	$19.83
86160		<1%	140	$18.73
94799		<1%	137	$17.10
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	1,827	$17.10
87205		<1%	61	$16.42
82948		<1%	508	$15.56
82784		<1%	117	$13.95
86677		<1%	18	$12.95
82105		<1%	71	$11.97
82378		<1%	114	$10.76
87045		<1%	97	$9.88
83516		<1%	164	$8.17
82247		<1%	82	$7.39
H1003	Prenatal care, at-risk enhanced service; education	<1%	132	$6.73
85045		<1%	62	$5.98
84132		<1%	73	$4.09
84520		<1%	126	$3.11
84156		<1%	106	$2.58
81005		<1%	432	$0.35
G8420	Bmi is documented within normal parameters and no follow-up plan is required	0%	113	$0.00
3074F		0%	2,605	$0.00
92082		0%	27	$0.00
99441		0%	387	$0.00
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	0%	351	$0.00
86141		0%	110	$0.00
84154		0%	61	$0.00
82951		0%	38	$0.00
2000F		0%	126	$0.00
82670		0%	73	$0.00
3075F		0%	110	$0.00
94761		0%	217	$0.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	168	$0.00
3079F		0%	463	$0.00
96110	Developmental screening, with scoring and documentation, per standardized instrument	0%	294	$0.00
1126F		0%	64	$0.00
84478		0%	12	$0.00
3044F		0%	78	$0.00
2001F		0%	379	$0.00
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	183	$0.00
A0999	Unlisted ambulance service	0%	112	$0.00
1036F		0%	14	$0.00
4245F		0%	253	$0.00
96150		0%	60	$0.00
96151		0%	17	$0.00
H0002	Behavioral health screening to determine eligibility for admission to treatment program	0%	215	$0.00
90585		0%	136	$0.00
82120		0%	149	$0.00
2010F		0%	125	$0.00
1000F		0%	85	$0.00
H0049	Alcohol and/or drug screening	0%	12	$0.00
87046		0%	92	$0.00
92060		0%	66	$0.00
12001		0%	12	$0.00
3080F		0%	41	$0.00
86800		0%	71	$0.00
82040		0%	54	$0.00
36410		0%	15	$0.00
83704		0%	12	$0.00
86317		0%	12	$0.00
0001F		0%	114	$0.00
77063	Screening digital breast tomosynthesis, bilateral	0%	13	$0.00
86060		0%	129	$0.00
99406		0%	257	$0.00
92499		0%	28	$0.00
99443		0%	21	$0.00
82435		0%	18	$0.00
83050		0%	13	$0.00
4037F		0%	61	$0.00
A0398	Als routine disposable supplies	0%	29	$0.00
1170F		0%	30	$0.00
3352F		0%	30	$0.00
83520		0%	14	$0.00
0545F		0%	30	$0.00
92226		0%	20	$0.00
90698		0%	13	$0.00
97032		0%	45	$0.00
1220F		0%	13	$0.00
92250		0%	13	$0.00
86780		0%	13	$0.00
92081		0%	1,683	$0.00
87209		0%	156	$0.00
95144		0%	316	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	183	$0.00
3078F		0%	2,267	$0.00
3725F		0%	134	$0.00
90461		0%	223	$0.00
1160F		0%	464	$0.00
G0444	Annual depression screening, 5 to 15 minutes	0%	1,116	$0.00
G9920	Screening performed and negative	0%	1,026	$0.00
G0270	Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes	0%	292	$0.00
S9470	Nutritional counseling, dietitian visit	0%	148	$0.00
99051		0%	316	$0.00
96160		0%	258	$0.00
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	0%	89	$0.00
3028F		0%	136	$0.00
1158F		0%	16	$0.00
88112		0%	15	$0.00
1159F		0%	247	$0.00
92568		0%	491	$0.00
99053		0%	119	$0.00
G9744	Patient not eligible due to active diagnosis of hypertension	0%	39	$0.00
82465		0%	246	$0.00
82310		0%	103	$0.00
87427		0%	87	$0.00
G0402	Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment	0%	16	$0.00
99442		0%	195	$0.00
86039		0%	140	$0.00
86200		0%	210	$0.00
99080		0%	31	$0.00
0521F		0%	30	$0.00
4005F		0%	30	$0.00
99072		0%	567	$0.00
83026		0%	69	$0.00
83525		0%	12	$0.00
83037		0%	26	$0.00
86708		0%	70	$0.00
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	0%	294	$0.00
86765		0%	19	$0.00
86235		0%	126	$0.00
86787		0%	12	$0.00
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	0%	29	$0.00
83020		0%	12	$0.00
3288F		0%	13	$0.00
82627		0%	26	$0.00
76857		0%	13	$0.00
3077F		0%	26	$0.00
99152		0%	12	$0.00
84165		0%	12	$0.00
95930		0%	13	$0.00
99421		0%	52	$0.00
84295		0%	18	$0.00
G9919	Screening performed and positive and provision of recommendations	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGHAEMIAN, SHADAN (PRESIDENT)